Revenue, Contract Assets and Liabilities and Other Contract Matters - Schedules of Concentration of Risk, by Risk Factor (Parenthetical) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Disaggregation of Revenue [Line Items] | ||
| Litigation Settlement, Expense | $ 32.5 | |
| Previous MPSV Litigation | ||
| Disaggregation of Revenue [Line Items] | ||
| Litigation Settlement, Expense | $ 32.5 | |
| Sales Revenue, Net | Customer Concentration Risk | Customer C | ||
| Disaggregation of Revenue [Line Items] | ||
| Concentration risk, percentage | 10.00% | |
| Sales Revenue, Net | Customer Concentration Risk | Customer D | ||
| Disaggregation of Revenue [Line Items] | ||
| Concentration risk, percentage | 10.00% | |
| Sales Revenue, Net | Customer Concentration Risk | Maximum | ||
| Disaggregation of Revenue [Line Items] | ||
| Concentration risk, percentage | 10.00% | 10.00% |
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|